1. Home
  2. NAMS
  3. NAMS News

Latest NewAmsterdam Pharma Company N.V. (NAMS) News on July 26, 2024

NewAmsterdam Pharma to Announce Topline Data from Pivotal Phase 3 BROOKLYN Clinical Trial Evaluating Obicetrapib in Patients with Heterozygous Familial Hypercholesterolemia on Monday, July 29, 2024

GlobeNewswire

3 hours ago

NewAmsterdam Pharma to Announce Topline Data from Pivotal Phase 3 BROOKLYN Clinical Trial Evaluating Obicetrapib in Patients with Heterozygous Familial Hypercholesterolemia on Monday, July 29, 2024

Thomson Reuters StreetEvents

6 months ago

Q4 2023 Hub Group Inc Earnings Call

Morningstar Research

6 months ago

Analyst Report: Hub Group, Inc.

BGC stock jumps on upbeat Q4 outlook

Yahoo Finance Video

7 months ago

BGC stock jumps on upbeat Q4 outlook

Share on Social Networks: